Clinical trials
ARDS (Moderate or Severe) clinical trials
Below are recruiting ards (moderate or severe) clinical trials, each written for real people, not researchers. We’re tracking 1,504 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06702761Recruiting
Depression among heart surgery healthcare workers in Baghdad
This study aims to find out how common and how severe depression is among healthcare workers in cardiothoracic surgery departments in Baghdad. It uses a questionnaire called PHQ-9 to screen for depression symptoms.
BaghdadAges 18 years+ - NCT07543380RecruitingPhase 3
RSV vaccine safety and immune response in high-risk adults
This study tests a new RSV vaccine designed to protect adults with chronic health conditions from severe RSV disease (a respiratory infection). Researchers will monitor how safe the vaccine is and how well your immune system responds to it.
Tsuchiura, IbarakiAges 18–59 - NCT07093788Recruiting
Comparing two ways to treat hard calcium in heart arteries
This trial tests two methods for breaking up heavy calcium buildup in heart arteries before placing a stent. It compares a specialized high-pressure balloon to a device that uses shockwaves.
Lianyungang, JiangsuAges 18–80 - NCT05981274Recruiting
Bone health study of a long-acting factor VIII for hemophilia A
This study tests whether a long-acting factor VIII medicine (rFVIIIFc) helps protect the bones and joints of people with hemophilia A. If you have severe or moderate hemophilia with joint damage and are already on this treatment, you may be able to join.
Taipei, Neihu Dist.Ages Any age - NCT07052409Enrolling by invitation
Protecting HIV-exposed infants from severe infections
This trial studies ways to protect babies who were exposed to HIV before birth but are not infected themselves. It aims to find better interventions to prevent severe infections in these infants.
JohannesburgAges 6 months–45 years - NCT07127224Recruiting
Predicting recovery with smell tests in coma
This study tests whether a simple smell test can help predict recovery of consciousness in patients who remain in a coma or minimally conscious state after a severe brain injury. If you or your loved one has been unresponsive for several days after sedation is stopped, this trial may provide useful information about prognosis.
Paris, GHU Psychiatrie Et NeurosciencesAges 18 years+ - NCT07123207Recruiting
Probiotic with infliximab for Crohn's disease
This study is testing whether adding a probiotic (Bacillus subtilis) to standard infliximab treatment can improve outcomes for people with active Crohn's disease. It aims to see if the probiotic helps the medication work better.
Changsha, HunanAges 18–75 - NCT07119086Recruiting
Arbovirus infection study in the Indian Ocean
This study looks at patients with suspected, probable, or confirmed arbovirus infections (like dengue, chikungunya, or Zika) to understand what factors lead to hospitalization and how severe the illness can be. It may include adults, children, and even newborns if they might have been exposed.
Saint-PierreAges Any age - NCT05122078Recruiting
Test pain treatment guided by a heart-based index after bowel surgery
This trial studies whether using a monitor-based pain number (called the ANI) to guide pain medicine can improve bowel function after laparoscopic surgery for colorectal cancer. It may help reduce constipation or slow gut recovery by matching pain treatment to your body’s signals.
SeoulAges 19 years+ - NCT06735885Recruiting
Brain training with feedback app for depression
This trial tests whether a smartphone app combined with brain scanning (fMRI) can help people with depression. You will get real-time feedback on your brain activity to learn how to improve your mood.
Stanford, CaliforniaAges 18–80 - NCT06740396Recruiting
Depression in heart disease patients in Baghdad
This study looks at how common depression is in people with coronary artery disease and how severe it is. If you have heart disease and are being treated at a hospital in Baghdad, you can help doctors understand the link between heart health and mental health.
BaghdadAges 18 years+ - NCT04817540RecruitingPhase 2
Testing anti-HER2 treatment for HER2-enriched early breast cancer
This trial tests an anti-HER2 medicine in people whose breast cancer is classified as “HER2-enriched” using a special lab test (PAM50). It aims to see whether this treatment can help prevent or control cancer that cannot be fully removed by surgery.
SeoulAges 19 years+ - NCT06761209Recruiting
Autoantibody negativity and autoimmune hepatitis severity
This trial checks if the absence of certain antibodies in autoimmune hepatitis (AIH) is linked to more severe disease. It may help doctors better understand and treat AIH.
Paris, FranceAges 18 years+ - NCT06762184Recruiting
Pain scores in serious brain surgery patients after ICU care
This study looks back at patients who had brain surgery and were in the intensive care unit (ICU) for more than 24 hours. Researchers want to learn about their pain scores, which can help improve care for future patients.
Beijing, BeijingAges 18 years+ - NCT07700095Recruiting
Comparing two ways to rebuild jawbone for dental implants
This trial tests two ways to rebuild bone in the back lower jaw using special barriers (custom 3D zirconia or titanium mesh) to support a dental implant. It may help if you have severe bone loss and want an implant.
Kafr ElsheikhAges 20–50 - NCT06456931Recruiting
Buddhist vs. secular mindfulness for lingering depression
This study compares two types of mindfulness training for people with lingering depression symptoms (not fully recovered). One uses traditional Buddhist meditation, the other uses a common secular approach. It aims to see which helps reduce residual depression better.
Ragama, GampahaAges 18 years+ - NCT06508710RecruitingPhase 3
Ketamine plus venlafaxine for severe depression
This trial tests whether adding ketamine to the antidepressant venlafaxine helps relieve severe depression faster than venlafaxine alone. If you are hospitalized for a serious depression and you meet safety criteria, you may be eligible.
Le Kremlin-Bicêtre, FranceAges 18–65 - NCT07262645RecruitingPhase 3
Light therapy for mild to moderate Alzheimer's disease
This study tests a near-infrared light therapy device for people with mild to moderate Alzheimer's disease. It may help with memory and thinking by using light on the head, a non-invasive approach.
Beijing, Beijing MunicipalityAges 50–85 - NCT04602962Recruiting
Fertility treatments and fertility preservation study
This study looks at how safe and effective fertility treatments are and how well fertility preservation options work. It is meant for people who are struggling to get pregnant or who need to protect their future fertility.
StockholmAges Up to 56 years - NCT04537182Recruiting
Surgery versus bronchoscopy for severe emphysema
This study compares two ways to reduce lung “overinflation” in people with severe emphysema: surgery (LVRS) or a bronchoscopy procedure (BLVR). It aims to see which approach works best and is safest for eligible patients.
ViennaAges 30–80 - NCT06455800Recruiting
Severe lung disease in childhood
This study looks at severe lung disease in children. It may help doctors better understand and treat these conditions.
OdenseAges 1 day–18 years - NCT05912517RecruitingPhase 3
Nipocalimab for high-risk pregnancy blood disease
This Phase 3 trial tests nipocalimab (an antibody medicine) to help prevent severe blood breakdown in a baby when a parent has certain blood antibodies. It enrolls people who previously had severe hemolytic disease in a past pregnancy and who are currently early in pregnancy with the same risk antibodies.
La Jolla, CaliforniaAges 18–45 - NCT07413887Recruiting
Family program for obsessive thoughts and behaviors in youth
This trial tests a family-based program for children and teens with mild to moderate obsessive thoughts or compulsive behaviors. It aims to help reduce distress and improve daily functioning at home and school.
FrederiksbergAges 3–17 - NCT06426290Recruiting
Predicting success after weight-loss surgery
This study looks at whether a psychological test can help predict who will do well after weight-loss surgery. Researchers are reviewing past test results and surgery outcomes to find patterns.
MoulinsAges 18 years+
Hear when a new ARDS (Moderate or Severe) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for ards (moderate or severe)?
- Yes. Clin2 currently lists 1,504 recruiting ards (moderate or severe) studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a ards (moderate or severe) trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a ards (moderate or severe) trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.